Compounds > ciglitazone
Page last updated: 2024-10-25

ciglitazone and Delayed Hypersensitivity

ciglitazone has been researched along with Delayed Hypersensitivity in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
VanBuskirk, AM1
Lesinski, GB1
Nye, KJ1
Carson, WE1
Yee, LD1

Other Studies

1 other study available for ciglitazone and Delayed Hypersensitivity

ArticleYear
TGF-beta inhibition of CTL re-stimulation requires accessory cells and induces peroxisome-proliferator-activated receptor-gamma (PPAR-gamma).
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:8

    Topics: Antigen-Presenting Cells; Cell Line; Gene Expression Regulation; Herpesvirus 4, Human; Humans; Hyper

2006